KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Payables (2016 - 2025)

Charles River Laboratories International has reported Payables over the past 17 years, most recently at $148.8 million for Q4 2025.

  • For Q4 2025, Payables rose 6.03% year-over-year to $148.8 million; the TTM value through Dec 2025 reached $148.8 million, up 6.03%, while the annual FY2025 figure was $148.8 million, 6.03% up from the prior year.
  • Payables for Q4 2025 was $148.8 million at Charles River Laboratories International, down from $169.6 million in the prior quarter.
  • Over five years, Payables peaked at $226.0 million in Q1 2022 and troughed at $110.9 million in Q2 2021.
  • A 5-year average of $155.4 million and a median of $143.1 million in 2024 define the central range for Payables.
  • Biggest five-year swings in Payables: skyrocketed 90.56% in 2022 and later crashed 46.9% in 2023.
  • Year by year, Payables stood at $198.1 million in 2021, then rose by 3.93% to $205.9 million in 2022, then fell by 17.96% to $168.9 million in 2023, then fell by 16.93% to $140.3 million in 2024, then increased by 6.03% to $148.8 million in 2025.
  • Business Quant data shows Payables for CRL at $148.8 million in Q4 2025, $169.6 million in Q3 2025, and $145.8 million in Q2 2025.